Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study

被引:6
|
作者
Yildiz, Gulsen Babacan [1 ]
Kayacan, Zeynep Cigdem [2 ]
Karacan, Ilker [3 ]
Sumbul, Bilge [4 ]
Elibol, Birsen [5 ]
Gelisin, Ozlem [1 ]
Akgul, Ozer [2 ,6 ]
机构
[1] Bezmialem Vakif Univ, Fac Med, Dept Neurol, Istanbul, Turkiye
[2] Istanbul Hlth & Technol Univ, Fac Med, Dept Med Microbiol, Istanbul, Turkiye
[3] Istanbul Medeniyet Univ, Fac Engn & Nat Sci, Sci & Adv Technol Res Ctr, Mol Biol & Genet, Istanbul, Turkiye
[4] Bezmialem Vakif Univ, Fac Med, Dept Med Microbiol, Istanbul, Turkiye
[5] Istanbul Medeniyet Univ, Fac Med, Dept Med Biol, Istanbul, Turkiye
[6] Istanbul Aydin Univ, Fac Med, Dept Med Microbiol, Istanbul, Turkiye
关键词
Parkinson's disease; Gut microbiota; Non-motor symptoms; 16S rRNA sequencing; ALPHA-SYNUCLEIN; BRAIN AXIS; BACTERIAL; RISK;
D O I
10.1007/s13760-023-02195-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThe investigations related to how gut microbiota changes the brain-gut axis in idiopathic Parkinson's disease (PD) attract growing interest. We aimed to determine whether gut microbiota is altered in PD patients and whether non-motor symptoms of PD and disease duration had any relation with alterations of microbiota profiles among patients.MethodsMicrobial taxa in stool samples obtained from 84 subjects (42-PD patients and 42-healthy spouses) were analyzed using 16S rRNA amplicon-sequencing.ResultsWe observed a significant decrease of Firmicutes and a significant increase of Verrucomicrobiota at the phylum level. At the family level, Lactobacillaceae and Akkermansiaceae were significantly increased and Coriobacteriales Incertae Sedis were significantly decreased in the PD patients compared to their healthy spouses. Genus level comparison inferred significant increase in abundance only in Lactobacillus while the abundance of Lachnospiraceae ND3007 group, Tyzzerella, Fusicatenibacter, Eubacterium hallii group and Ruminococcus gauvreauii group were all decreased. We determined that the abundance of Prevotella genus decreased, but not significantly in PD patients. In addition, we found differences in microbiota composition between patients with and without non-motor symptoms.ConclusionWe observed differences in gut microbiota composition between PD patients and their healthy spouses. Our findings suggest that disease duration influenced microbiota composition, which in turn influenced development of non-motor symptoms in PD. This study is the first in terms of both gut microbiota research in Turkish PD patients and the probable effect of microbiota on non-motor symptoms of PD.
引用
收藏
页码:999 / 1009
页数:11
相关论文
共 50 条
  • [31] DEPRESSION IN PARKINSON'S DISEASE: A CASE-CONTROL STUDY
    Chang, M. -H.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E10 - E10
  • [32] Case-control study of hypertension and Parkinson's disease
    Ng, Yuen-Fann
    Ng, Ebonne
    Lim, Ee-Wei
    Prakash, Kumar M.
    Tan, Louis C. S.
    Tan, Eng-King
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [33] Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
    Unger, Marcus M.
    Spiegel, Joerg
    Dillmann, Klaus-Ulrich
    Grundmann, David
    Philippeit, Hannah
    Buermann, Jan
    Fassbender, Klaus
    Schwiertz, Andreas
    Schaefer, Karl-Herbert
    PARKINSONISM & RELATED DISORDERS, 2016, 32 : 66 - 72
  • [34] Do Parkinson's disease medications have an effect on gut microbiome? A case-control study
    Zhang, P.
    Huang, P.
    Qian, Y.
    Yang, X.
    He, Y.
    Du, J.
    Li, G.
    Cui, S.
    Xu, S.
    Liu, J.
    Lin, Y.
    Fu, Y.
    He, G.
    Zhang, Z.
    Xiao, Q.
    Chen, S.
    MOVEMENT DISORDERS, 2021, 36 : S460 - S463
  • [35] Analysis of Gut Microbiota in Patients with Parkinson's Disease
    Petrov, V. A.
    Saltykova, I. V.
    Zhukova, I. A.
    Alifirova, V. M.
    Zhukova, N. G.
    Dorofeeva, Yu. B.
    Tyakht, A. V.
    Kovarsky, B. A.
    Alekseev, D. G.
    Kostryukova, E. S.
    Mironova, Yu. S.
    Izhboldina, O. P.
    Nikitina, M. A.
    Perevozchikova, T. V.
    Fait, E. A.
    Babenko, V. V.
    Vakhitova, M. T.
    Govorun, V. M.
    Sazonov, A. E.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 162 (06) : 734 - 737
  • [36] Analysis of Gut Microbiota in Patients with Parkinson’s Disease
    V. A. Petrov
    I. V. Saltykova
    I. A. Zhukova
    V. M. Alifirova
    N. G. Zhukova
    Yu. B. Dorofeeva
    A. V. Tyakht
    B. A. Kovarsky
    D. G. Alekseev
    E. S. Kostryukova
    Yu. S. Mironova
    O. P. Izhboldina
    M. A. Nikitina
    T. V. Perevozchikova
    E. A. Fait
    V. V. Babenko
    M. T. Vakhitova
    V. M. Govorun
    A. E. Sazonov
    Bulletin of Experimental Biology and Medicine, 2017, 162 : 734 - 737
  • [37] Sleep disorders in Parkinson's disease patients. A case-control study
    Rotaru, L.
    Cebuc, M.
    Or, A. Lupus Comma
    Grosu, O.
    Odobescu, S.
    Gavriliuc, O.
    Moldovanu, I.
    MOVEMENT DISORDERS, 2023, 38 : S214 - S214
  • [38] Pulmonary function tests in patients with Parkinson's disease: A case-control study
    Owolabi, L. F.
    Nagoda, M.
    Babashani, M.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2016, 19 (01) : 66 - 70
  • [39] Assessment of sexual dysfunction in patients with Parkinson's disease: a case-control study
    Celikel, E.
    Ozel-Kizil, E. T.
    Akbostanci, M. C.
    Cevik, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (11) : 1168 - 1172
  • [40] Hydrocarbon exposure in patients with Parkinson's disease in Milan: A case-control study
    Canesi, M
    Colombo, A
    Mariani, C
    Tesei, S
    Pezzoli, G
    NEUROLOGY, 2001, 56 (08) : A118 - A118